Would you like to join our distribution list or receive press releases electronically? Register here: https://www.hochdorf.com/en/newsletter
Do you have any questions about the HOCHDORF Group? Please contact:
Marlène Betschart
Head Corporate Communication & Investor Relations
HOCHDORF-Gruppe
Tel. +41 41 914 65 83
Mobile +41 79 245 24 10
marlene.betschart@hochdorf.com
- 22.04HOCHDORF publishes agenda for the Annual General Meeting and provides information on financial legacy and prospects
- 21.03Positive operating result for HOCHDORF – approach of investors launched
- 05.03HOCHDORF: Update on 2023 business performance and strategic options for financial restructuring
- 11.09Hochdorf production site to remain in operation until the end of 2026
- 24.08HOCHDORF on course operationally: pleasing first half year
- 23.03HOCHDORF makes significant operational progress and gains time
- 15.11CFO change at the HOCHDORF Group
- 08.08HOCHDORF: Pleasing net sales revenue – material and energy costs negatively influence half-year result
- 22.06CFO change at the HOCHDORF Group
- 14.03Pleasing balance sheet improvement and difficult milk year
- 21.01Peter Pfeilschifter to leave HOCHDORF Swiss Nutrition Ltd - Ralph Siegl appointed CEO
- 16.12HOCHDORF sells site to the Hochdorf municipality
- 31.08HOCHDORF takes next steps towards financial recovery and strategic focus
- 16.08Interim Results 2021: Creating a solid foundation for a successful future
- 28.06HOCHDORF reaches agreement with syndicate banks
- 09.06Shareholders accept Board of Directors’ recommendations
- 12.04HOCHDORF – strategic and operational foundations developed
- 10.03HOCHDORF postpones Annual Results Press Conference and Annual General Meeting
- 18.12HOCHDORF to sell Marbacher Ölmühle
- 01.10HOCHDORF extends deadline for part of the final payment from the sale of Pharmalys
- 23.09HOCHDORF and BIMBOSAN move together to strengthen the "Bimbosan" brand
- 17.08Recent measures are taking effect
- 22.072020 interim results better than previous year
- 30.06Jürg Oleas is elected as Chair of the Board of Directors
- 25.06Geza Somogyi appointed COO of the HOCHDORF Group
- 15.06Answers to the shareholder questions to the AGM on Agenda Item 8
- 05.06Information about the Annual General Meeting on 30 June 2020
- 25.05Nanette Haubensak appointed CFO of the HOCHDORF Group
- 06.05HOCHDORF Group continues to sharpen its focus
- 19.032019: A challenging year of transformation
- 26.02HOCHDORF to part from German milk plant
- 18.02Board of Directors of HOCHDORF must be recomposed
- 16.01Our response to questions raised by Stichting General Holdings
- 19.12Dr Peter Pfeilschifter appointed CEO of the HOCHDORF Group
- 19.12HOCHDORF Group receives motion to convene Extraordinary General Meeting
- 13.12Closing of the sale of the Pharmalys stake to Pharmalys Invest Holding
- 08.12HOCHDORF sells Pharmalys stake to Pharmalys Invest Holding
- 14.11Jürgen Brandt appointed new CFO of the HOCHDORF Group
- 21.08Amir Mechria resigns from the Board of Directors of Pharmalys Laboratories SA
- 20.08HOCHDORF must realign itself
- 07.08Sale of HOCHDORF South Africa Ltd
- 08.07HOCHDORF realigns its business
- 13.05Integration of subsidiaries bigger challenge than expected – strategy update announced
- 12.04Shareholders focus on fresh impetus – HOCHDORF receives four new board members
- 19.03Implementation of strategy continues – expected earnings not yet realised
- 13.03Nominations for the Board of Directors
- 11.03Dr Thomas Eisenring resigns as CEO
- 10.12Sales delays and inventory write-downs impact net income
- 21.11Milk from Eastern Switzerland for HOCHDORF infant formula
- 30.08HOCHDORF expecting a significant improvement in the second half of the year
- 18.07Michel Burla to leave the HOCHDORF Group at the end of this year
- 19.06HOCHDORF parts company with milk plant in Lithuania
- 24.05HOCHDORF takes over traditional Swiss brand Bimbosan
- 07.05Dividend increase thanks to good result
- 05.04HOCHDORF: Successful forward integration
- 29.03Werner Schweizer is succeeded by Dr Peter Pfeilschifter
- 31.01Dr Karl Gschwend to retire
- 21.11HOCHDORF successfully places public hybrid bond (SIX/
- 14.11HOCHDORF presents a new quality standard for oils
- 01.11HOCHDORF strengthens its position in Cereals & Ingredients
- 17.08Higher earnings thanks to Pharmalys’ participation
- 04.07Uckermärker Milch to reposition itself on the market
- 08.05Dr Daniel Suter takes on the role of Chairman
- 28.03Closing of the Offering
- 13.03Launch of the mandatory convertible securities
- 13.03HOCHDORF posts record earnings in 2016
- 26.01Sales maintained at last year’s level despite low milk price